Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
45.61B | 47.29B | 42.82B | 38.61B | 43.96B | 39.67B | Gross Profit |
9.77B | 10.06B | 9.49B | 8.63B | 8.93B | 9.59B | EBIT |
2.42B | 2.67B | 2.13B | 1.74B | 2.37B | 2.37B | EBITDA |
2.39B | 2.87B | 2.11B | 1.93B | 2.56B | 2.56B | Net Income Common Stockholders |
1.40B | 1.77B | 1.21B | 1.10B | 1.49B | 1.54B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.23B | 5.97B | 3.77B | 3.25B | 2.51B | 2.54B | Total Assets |
18.99B | 20.18B | 18.07B | 16.93B | 16.09B | 16.77B | Total Debt |
438.00M | 399.00M | 654.00M | 1.07B | 1.61B | 2.20B | Net Debt |
-3.79B | -5.57B | -1.25B | -2.19B | -902.00M | -339.00M | Total Liabilities |
7.69B | 8.22B | 7.66B | 7.52B | 7.56B | 7.82B | Stockholders Equity |
11.19B | 11.84B | 10.31B | 9.32B | 8.45B | 8.89B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.70B | 1.14B | 1.53B | 758.00M | 1.09B | Operating Cash Flow |
0.00 | 2.94B | 1.43B | 1.83B | 996.00M | 1.35B | Investing Cash Flow |
0.00 | -604.00M | -316.00M | -710.00M | -606.00M | -650.00M | Financing Cash Flow |
0.00 | -498.00M | -628.00M | -771.00M | -816.00M | -215.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥13.43B | 7.58 | 3.05% | -1.59% | -7.30% | ||
80 Outperform | ¥17.56B | 14.96 | 5.22% | 1.50% | -18.82% | ||
79 Outperform | ¥9.45B | 5.35 | 3.43% | 10.44% | 46.04% | ||
73 Outperform | ¥26.24B | 6.15 | 8.17% | -10.85% | 25.59% | ||
71 Outperform | ¥9.60B | 15.48 | 1.57% | 23.68% | 577.69% | ||
68 Neutral | ¥17.95B | 4.91 | 4.73% | 21.35% | 221.64% | ||
62 Neutral | $11.89B | 9.95 | -7.22% | 4.98% | 7.31% | -8.91% |